Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Justman

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Journal of Women'S Health (2002)|April 19, 2014
Venue-based recruitment of women at elevated risk for HIV: an HIV Prevention Trials Network studyDanielle F Haley, Carol Golin, Wafaa El-Sadr, et al.
Plos One|May 4, 2019
Methods, outcomes, and costs of a 2.5 year comprehensive facility-and community-based HIV testing intervention in Bukoba Municipal Council, Tanzania, 2014-2017Haddi Jatou Cham, Duncan MacKellar, Haruka Maruyama, et al.
JNCI Cancer Spectrum|July 11, 2024
Prevalence of monoclonal gammopathy of undetermined significance in Eswatini: a population-based study in AfricaKara I Cicero, Xolisile Dlamini, Yvonne Mavengere, et al.
Journal of the International AIDS Society|November 25, 2017
Returning HIV-1 viral load results to participant-selected health facilities in national Population-based HIV Impact Assessment (PHIA) household surveys in three sub-Saharan African Countries, 2015 to 2016Suzue Saito, Yen T Duong, Melissa Metz, et al.
Trials|June 18, 2020
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialChristina M Eckhardt, Matthew J Cummings, Kartik N Rajagopalan, et al.
Plos One|June 3, 2022
High HIV incidence among young women in South Africa: Data from a large prospective studyThesla Palanee-Phillips, Helen V Rees, Kate B Heller, et al.
Trials|November 18, 2020
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialChristina M Eckhardt, Matthew J Cummings, Kartik N Rajagopalan, et al.
Trials|June 10, 2020
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialChristina M Eckhardt, Matthew J Cummings, Kartik N Rajagopalan, et al.
PLOS Global Public Health|October 24, 2024
Promising results of HIV prevention trials highlight the benefits of collaboration in global health: The perspective of the Forum HIV Recency Assay Working GroupRobin Schaefer, Logan Donaldson, Mitchell Leus, et al.
AIDS Research and Human Retroviruses|November 19, 2022
HIV Incidence, Recent HIV Infection, and Associated Factors, Kenya, 2007-2018Peter Wesley Young, Paul Musingila, Leonard Kingwara, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of Women'S Health (2002)|April 19, 2014
Venue-based recruitment of women at elevated risk for HIV: an HIV Prevention Trials Network studyDanielle F Haley, Carol Golin, Wafaa El-Sadr, et al.
Plos One|May 4, 2019
Methods, outcomes, and costs of a 2.5 year comprehensive facility-and community-based HIV testing intervention in Bukoba Municipal Council, Tanzania, 2014-2017Haddi Jatou Cham, Duncan MacKellar, Haruka Maruyama, et al.
JNCI Cancer Spectrum|July 11, 2024
Prevalence of monoclonal gammopathy of undetermined significance in Eswatini: a population-based study in AfricaKara I Cicero, Xolisile Dlamini, Yvonne Mavengere, et al.
Journal of the International AIDS Society|November 25, 2017
Returning HIV-1 viral load results to participant-selected health facilities in national Population-based HIV Impact Assessment (PHIA) household surveys in three sub-Saharan African Countries, 2015 to 2016Suzue Saito, Yen T Duong, Melissa Metz, et al.
Trials|June 18, 2020
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialChristina M Eckhardt, Matthew J Cummings, Kartik N Rajagopalan, et al.
Plos One|June 3, 2022
High HIV incidence among young women in South Africa: Data from a large prospective studyThesla Palanee-Phillips, Helen V Rees, Kate B Heller, et al.
Trials|November 18, 2020
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialChristina M Eckhardt, Matthew J Cummings, Kartik N Rajagopalan, et al.
Trials|June 10, 2020
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialChristina M Eckhardt, Matthew J Cummings, Kartik N Rajagopalan, et al.
PLOS Global Public Health|October 24, 2024
Promising results of HIV prevention trials highlight the benefits of collaboration in global health: The perspective of the Forum HIV Recency Assay Working GroupRobin Schaefer, Logan Donaldson, Mitchell Leus, et al.
AIDS Research and Human Retroviruses|November 19, 2022
HIV Incidence, Recent HIV Infection, and Associated Factors, Kenya, 2007-2018Peter Wesley Young, Paul Musingila, Leonard Kingwara, et al.
Pageof 9